Physician profile
Daniel Vukas
NPI 1013993005
$1,213.38
in general payments reported to CMS, 2019-2025
14 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.13 · 2021: $245 · 2022: $113 · 2023: $34.62 · 2024: $519 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $244.49 | 2023-2025 | Inspire |
| Medtronic, INC. | $150.00 | 2021 | |
| Stryker Corporation | $147.96 | 2020-2025 | Xpress Loprofile, Audion Et Dilation System |
| Optinose US, INC. | $128.35 | 2022-2025 | |
| Genzyme Corporation | $95.93 | 2024-2025 | |
| Smith+Nephew, INC. | $91.76 | 2023-2025 | Tula, Halo, Coblation |
| Acclarent, INC | $90.98 | 2021-2022 | |
| Itamar Medical INC | $52.94 | 2022-2024 | Watchpatone |
| Glaxosmithkline, LLC. | $47.34 | 2024-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $47.11 | 2020-2024 | Dupixent |
| Alk-Abello, INC | $43.33 | 2024 | Odactra, Grastek, Ragwitek |
| Integra Lifesciences Corporation | $25.74 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Checkpoint Surgical, INC | $24.95 | 2025 | Checkpoint Stimulators |
| Cochlear Americas | $22.50 | 2024 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Vukas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.